Cowen analyst Phil Nadeau downgraded Frequency Therapeutics to Market Perform from Outperform.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FREQ:
Cowen analyst Phil Nadeau downgraded Frequency Therapeutics to Market Perform from Outperform.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FREQ: